Drug policies have traditionally sought to suppress supply and deter use through the application of punitive laws. Today, there is a growing recognition that these drug policies have not only failed to reach their objectives but have resulted in a great deal of collateral damage. Drug policy must be reformed to focus on health, human rights and development objectives, with the aim of making the market less harmful rather than necessarily reducing its size.
The Drug Policy Alliance reports on the danger of the new American fentanyl laws and states that the best way to reduce fentanyl-related deaths is through evidence-based public health and harm reduction approaches.
This fifth edition of the IDPC multilingual webinar series on the UN Commission on Narcotic Drugs (CND) focuses on its 63rd Session of the UN Commission on Narcotic Drugs (CND), which will take place in Vienna from 2-6 March 2020.